Alzheimer; News from the web:
Today we link to the article from Scientific American that tells the story about the reassessment of costs vs benefits for aducanumab.
Read all about it HERE
Category Archives: Research
Subtypes of Alzheimer’s
Alzheimer; News from the web:
In a new study in JAMA Neurology, a team of neuroscientists at Mayo Clinic in Florida led by Melissa Murray, Ph.D., examined a key region of the brain and found that patterns of Alzheimer’s-related damage differed by subtype and age of onset.
The researchers say these observations could have important treatment implications.
Read all about it HERE
Alzheimer surprise drug
Alzheimer; News from the web:
Despite many promising leads, more than 120 drug treatments for Alzheimer’s disease have failed. But Cambridge-based biotech company Biogen revived hope on Tuesday with its announcement that it would seek Food and Drug Administration approval for a drug it abandoned earlier this year.
Read all about it HERE
That new medicine for Alzheimer’s
Alzheimer; News from the web:
The biotech world went into a full-on frenzy Tuesday when drug giant Biogen dropped this whopper: The company is reviving its Alzheimer’s drug hopeful, aducanumab, after leaving it for dead all the way back in March. In fact, it’s marching forward with a Food and Drug Administration (FDA) application to approve the drug for certain patients facing cognitive decline.
Read all about it HERE
Ultra sound against Alzheimer’s
Alzheimer; News from the web:
Alzheimer’s symptoms are diminishing due to a treatment with ultrasound to allow medicine to get through the blood-brain barrier.
Read all about it HERE
New option in the fight against Alzheimer’s
Alzheimer; News from the web:
Researchers have now found that slower loss of cognitive skills in people with AD correlates with higher levels of a protein that helps immune cells clear plaque-like cellular debris from the brain [1]. The efficiency of this clean-up process in the brain can be measured via fragments of the protein that shed into the cerebrospinal fluid (CSF). This suggests that the protein, called TREM2, and the immune system as a whole, may be promising targets to help fight Alzheimer’s disease.
Read all about it HERE